Eyenovia Statistics
Total Valuation
Eyenovia has a market cap or net worth of $3.09 million. The enterprise value is $12.21 million.
Important Dates
The last earnings date was Tuesday, April 15, 2025, after market close.
Earnings Date | Apr 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Eyenovia has 2.83 million shares outstanding. The number of shares has increased by 62.41% in one year.
Current Share Class | 2.83M |
Shares Outstanding | 2.83M |
Shares Change (YoY) | +62.41% |
Shares Change (QoQ) | +39.64% |
Owned by Insiders (%) | 0.22% |
Owned by Institutions (%) | 2.68% |
Float | 2.82M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 15.84 |
Forward PS | 0.98 |
PB Ratio | -0.24 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 212.87 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.17
Current Ratio | 0.17 |
Quick Ratio | 0.15 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -15.11 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -144.58% |
Return on Invested Capital (ROIC) | -201.99% |
Return on Capital Employed (ROCE) | 303.19% |
Revenue Per Employee | $4,095 |
Profits Per Employee | -$3.56M |
Employee Count | 14 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.36% in the last 52 weeks. The beta is 1.20, so Eyenovia's price volatility has been higher than the market average.
Beta (5Y) | 1.20 |
52-Week Price Change | -97.36% |
50-Day Moving Average | 1.41 |
200-Day Moving Average | 28.14 |
Relative Strength Index (RSI) | 38.34 |
Average Volume (20 Days) | 48,349 |
Short Selling Information
The latest short interest is 123,238, so 4.35% of the outstanding shares have been sold short.
Short Interest | 123,238 |
Short Previous Month | 138,241 |
Short % of Shares Out | 4.35% |
Short % of Float | 4.36% |
Short Ratio (days to cover) | 0.27 |
Income Statement
In the last 12 months, Eyenovia had revenue of $57,336 and -$49.82 million in losses. Loss per share was -$59.81.
Revenue | 57,336 |
Gross Profit | -8.73M |
Operating Income | -37.53M |
Pretax Income | -32.44M |
Net Income | -49.82M |
EBITDA | -36.40M |
EBIT | -37.53M |
Loss Per Share | -$59.81 |
Full Income Statement Balance Sheet
The company has $2.12 million in cash and $11.24 million in debt, giving a net cash position of -$9.12 million or -$3.22 per share.
Cash & Cash Equivalents | 2.12M |
Total Debt | 11.24M |
Net Cash | -9.12M |
Net Cash Per Share | -$3.22 |
Equity (Book Value) | -13.10M |
Book Value Per Share | -8.69 |
Working Capital | -13.28M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$30.12 million and capital expenditures -$161,477, giving a free cash flow of -$30.28 million.
Operating Cash Flow | -30.12M |
Capital Expenditures | -161,477 |
Free Cash Flow | -30.28M |
FCF Per Share | -$10.70 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -65,456.83% |
Pretax Margin | -86,888.57% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Eyenovia does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -62.41% |
Shareholder Yield | -62.41% |
Earnings Yield | -1,614.56% |
FCF Yield | -981.42% |
Analyst Forecast
The average price target for Eyenovia is $2.00, which is 83.47% higher than the current price. The consensus rating is "Hold".
Price Target | $2.00 |
Price Target Difference | 83.47% |
Analyst Consensus | Hold |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 308.45% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on February 3, 2025. It was a reverse split with a ratio of 0.0125:1.
Last Split Date | Feb 3, 2025 |
Split Type | Reverse |
Split Ratio | 0.0125:1 |
Scores
Eyenovia has an Altman Z-Score of -110.92 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -110.92 |
Piotroski F-Score | 1 |